Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma
Conclusions:
A variant of opsoclonus-myoclonus-ataxia syndrome may occur following treatment with ipilimumab and nivolumab.
Source: Journal of Immunotherapy - Category: Allergy & Immunology Tags: Clinical Studies Source Type: research
More News: Asbestosis | Ataxia | Cancer | Cancer & Oncology | Clonazepam | Immunotherapy | Klonopin | Melanoma | Mesothelioma | Methylprednisolone | Skin Cancer | Study | Yervoy